Eulerpool Terminal
The edge that pays for itself.
Current ADMA Biologics forecasts and price targets in August 2026
Ø Analyst Price Targets
26.18 USD
+178.22 %
Median
30.60 USD
+225.19 %
Max
31.50 USD
Min
17.17 USD
Last Price
9.41 USD
Buy
8
Hold
1
Sell
0
The average target price for ADMA Biologics is 26.18 USD. (+178.22 % above the current price)
The median price target of ADMA Biologics is 30.60 USD.
Stock analysts from many renowned investment banks are closely examining the ADMA Biologics stock. They conclude their professional ADMA Biologics stock analyses with a clear recommendation for the ADMA Biologics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 8 | 1 | 0 | — |
| 2026-02-01 | 8 | 1 | 0 | 26.18 USD |
| 2026-02-01 | 8 | 1 | 0 | 26.18 USD |
| 2026-01-01 | 8 | 1 | 0 | 26.18 USD |
| 2025-12-01 | 9 | 1 | 0 | 26.18 USD |
| 2025-12-01 | 9 | 1 | 0 | 27.80 USD |
ADMA Biologics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for ADMA Biologics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 535.00 M USD | 195.00 M USD | 0.80 USD |
| 2027e | 700.00 M USD | 240.00 M USD | 0.98 USD |
| 2028e | 728.00 M USD | 343.00 M USD | 1.41 USD |